Abeona Therapeutics Inc

NASDAQ:ABEO   4:00:00 PM EDT
6.74
-0.27 (-3.85%)
: $6.87 +0.13 (+1.93%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Abeona Therapeutics Inc Stock, NASDAQ:ABEO

6555 Carnegie Avenue, 4th floor, Cleveland, Ohio 44103
United States of America
Phone: +1.646.813.4701
Number of Employees: 57

Description

Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in Cleveland, OH.